The goal of this grant is to determine the structural basis for specificity in protein kinase signaling. The hypothesis guiding this research is that specificity in protein kinase signaling is accomplished by the ability of multiple domains or regions of the kinase to simultaneously or sequentially form sequentially form sequence-specific contact with complimentary regions of the target proteins. For example, src-homology 2 and src-homology 3 domains (SH2 and SH3) can mediate interactions between protein-Tyr kinases and their targets. These domains can fold into tertiary structures independent of the whole protein and form pockets that are capable of specific interactions with other proteins or peptides. Specificity in signaling is partially provided by the ability of individual SH2 domains to recognize phosphotyrosine residues on the target protein within a specific sequence context. Likewise, individual SH3 domains are thought to recognize relatively short linear sequences to target proteins that are variations on a common structure. The catalytic cleft of the kinase domain also has selectivity for Tyr residues in a specific sequence context. The combination of individual selectivities of each of these domains insures high specificity in vivo. Here we propose to use a novel oriented peptide library approach to ascertain the optimal peptide sequences for binding to individual kinase catalytic domains as well as SH2 domains and other domains involved in targeting kinases. Since the tertiary structures of several members of each of these families of domains have been solved with high affinity peptides bound, it is possible in many cases to explain the selectivities observed and predict with residues are responsible for binding to side chains of the associated peptides. Mutations at these sites will be made and the oriented peptide libraries will be used to determine whether the selectivity has been altered. By this approach we hope to establish general principles that can be used to predict likely targets of domains on the basis of regions of homology with other domains. Algorithms based on the information from the peptide libraries will be designed to predict the most likely regions of interaction between specific domains and target proteins. These predictions will also be investigated. Ultimately, the models will be tested by the ability of mutations in specific domains of their targets to alter in vivo responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM056203-01
Application #
2372670
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1997-07-01
Project End
2001-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Israelsen, William J; Dayton, Talya L; Davidson, Shawn M et al. (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155:397-409
Carracedo, Arkaitz; Cantley, Lewis C; Pandolfi, Pier Paolo (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227-32
Chen, Sen; Jiang, Xinnong; Gewinner, Christina A et al. (2013) Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases. Sci Signal 6:ra40
Son, Jaekyoung; Lyssiotis, Costas A; Ying, Haoqiang et al. (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101-5
Yuan, Ping; Ito, Koichi; Perez-Lorenzo, Rolando et al. (2013) Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma. Proc Natl Acad Sci U S A 110:18226-31
Emerling, Brooke M; Benes, Cyril H; Poulogiannis, George et al. (2013) Identification of CDCP1 as a hypoxia-inducible factor 2ýý (HIF-2ýý) target gene that is associated with survival in clear cell renal cell carcinoma patients. Proc Natl Acad Sci U S A 110:3483-8
Shen, Che-Hung; Yuan, Ping; Perez-Lorenzo, Rolando et al. (2013) Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation. Mol Cell 52:161-72
Fendt, Sarah-Maria; Bell, Eric L; Keibler, Mark A et al. (2013) Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res 73:4429-38
Bettaieb, Ahmed; Bakke, Jesse; Nagata, Naoto et al. (2013) Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation. J Biol Chem 288:17360-71
Kim, Sang Gyun; Hoffman, Gregory R; Poulogiannis, George et al. (2013) Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. Mol Cell 49:172-85

Showing the most recent 10 out of 102 publications